The Global Fund to Fight AIDS, TB and Malaria is the largest funder of harm reduction globally, but its eligibility policy currently precludes certain Upper Middle Income Countries (UMICs) from applying for funding – with significant implications for people who use drugs and their access to essential services.

With changes to the eligibility policy up for discussion at a Global Fund Board meeting in early May 2018, Harm Reduction International calls for Board members to support changes that will help to achieve the goal of ending AIDS for people who inject drugs and other key populations.

In this briefing paper, Harm Reduction International analyses key elements of current policy including the OECD DAC Rule, the NGO Rule and the G20 Rule; and makes recommendations on sources of data and funding for advocacy.